Vemurafenib
#
Find similar titles
- (rev. 2)
- Hyungyong Kim
Structured data
- Image
- URL
- http://en.wikipedia.org/wiki/Vemurafenib
Vemurafenib (INN, marketed as Zelboraf) is a BRAF enzyme inhibitor developed by Plexxikon (now part of the Daiichi Sankyo group) and Genentech for the treatment of late-stage Melanoma.
Incoming Links #
Related Articles (Article 0) #
Related Drugs (Drug 1) #
Suggested Pages #
- 0.295 Nivolumab
- 0.147 Lung cancer
- 0.104 Receptor tyrosine kinase
- 0.091 Thyroid cancer
- 0.031 Cell signaling
- 0.029 Personalized medicine
- 0.025 Vectibix
- 0.024 Oncogene
- 0.024 B-Raf
- 0.024 MAPK
- More suggestions...